Scenarios that move KURA

Kura Oncology, Inc. - Common Stock

Scenarios that move KURA: 1 analysis, 1 positive, 0 negative.

  1. · Syndax stock falls 16% as Phase II fibrosis study misses primary goal — ▲ · impact +20 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing